Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Regenerative Medical Technology (RMTG) Long-Term Debt Repayments (2021 - 2023)

Historic Long-Term Debt Repayments for Regenerative Medical Technology (RMTG) over the last 3 years, with Q1 2023 value amounting to $9850.0.

  • Regenerative Medical Technology's Long-Term Debt Repayments rose 60558.74% to $9850.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $9850.0, marking a year-over-year decrease of 5258.95%. This contributed to the annual value of $9850.0 for FY2023, which is 5258.95% down from last year.
  • Regenerative Medical Technology's Long-Term Debt Repayments amounted to $9850.0 in Q1 2023, which was up 60558.74% from $6494.0 recorded in Q4 2022.
  • In the past 5 years, Regenerative Medical Technology's Long-Term Debt Repayments registered a high of $11427.0 during Q2 2022, and its lowest value of $1358.0 during Q4 2021.
  • Its 3-year average for Long-Term Debt Repayments is $5330.7, with a median of $3976.5 in 2022.
  • In the last 5 years, Regenerative Medical Technology's Long-Term Debt Repayments surged by 37820.32% in 2022 and then soared by 60558.74% in 2023.
  • Quarter analysis of 3 years shows Regenerative Medical Technology's Long-Term Debt Repayments stood at $1358.0 in 2021, then surged by 378.2% to $6494.0 in 2022, then soared by 51.68% to $9850.0 in 2023.
  • Its Long-Term Debt Repayments stands at $9850.0 for Q1 2023, versus $6494.0 for Q4 2022 and $1459.0 for Q3 2022.